Zobrazeno 1 - 10
of 908
pro vyhledávání: '"Se In Jung"'
Autor:
Jang-Woon Kim, Juryun Kim, Soon Min Lee, Yeri Alice Rim, Young Chul Sung, Yoojun Nam, Hyo-Jin Kim, Hyewon Kim, Se In Jung, Jooyoung Lim, Ji Hyeon Ju
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-20 (2024)
Abstract Background Spinal cord injury (SCI) is a disease that causes permanent impairment of motor, sensory, and autonomic nervous system functions. Stem cell transplantation for neuron regeneration is a promising strategic treatment for SCI. Howeve
Externí odkaz:
https://doaj.org/article/0131d7c54e7e43b2a06f1cac2c02f39a
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Osteoporosis is a metabolic bone disease that impairs bone mineral density, microarchitecture, and strength. It requires continuous management, and further research into new treatment options is necessary. Osteoprotegerin (OPG) inhibits bone
Externí odkaz:
https://doaj.org/article/8bd435edcb1c48aea531dd37037713eb
Autor:
Hyun-Soo Moon, Min Jung, Chong-Hyuk Choi, Kwangho Chung, Se-Han Jung, Junwoo Byun, Jin-Gyu Kim, Seungmin Lee, Sung-Hwan Kim
Publikováno v:
Knee Surgery & Related Research, Vol 36, Iss 1, Pp 1-10 (2024)
Abstract Background Research on factors influencing the outcomes of revision anterior cruciate ligament (ACL) reconstruction is relatively scarce and mostly relies even on reports from a single group. Understanding the factors contributing to the fai
Externí odkaz:
https://doaj.org/article/4c72a8b92eb249138267c89c14291047
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e59260 (2024)
BackgroundAccurate hospital length of stay (LoS) prediction enables efficient resource management. Conventional LoS prediction models with limited covariates and nonstandardized data have limited reproducibility when applied to the general population
Externí odkaz:
https://doaj.org/article/b58cbbd3a6c644bd96670a16bb8ef10f
Autor:
Sooyoung Yoo, Kahyun Lim, Se Young Jung, Keehyuck Lee, Donghyun Lee, Seok Kim, Ho-Young Lee, Hee Hwang
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background While various quantitative studies based on the Unified Theory of Acceptance and Use of Technology (UTAUT) and Technology Acceptance Models (TAM) exist in the general medical sectors, just a few have been conducted in the behavior
Externí odkaz:
https://doaj.org/article/4ca1c2b55d0440e9b03f6bf9cb673d2f
Autor:
San Wang, Jieun Han, Se Young Jung, Tae Jung Oh, Sen Yao, Sanghee Lim, Hee Hwang, Ho-Young Lee, Haeun Lee
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract This study aimed to develop a model to predict the 5-year risk of developing end-stage renal disease (ESRD) in patients with type 2 diabetes mellitus (T2DM) using machine learning (ML). It also aimed to implement the developed algorithms int
Externí odkaz:
https://doaj.org/article/ff358555ed9f4e4e9fa6ce3223a3c0a0
Publikováno v:
Clinical and Experimental Pediatrics, Vol 65, Iss 6, Pp 291-299 (2022)
As information communication technology (ICT) has advanced, the healthcare industry has embraced it to reduce medical costs, improve health outcomes, and increase patient satisfaction. Healthcare ICT revolutionizes pediatric healthcare. This study ai
Externí odkaz:
https://doaj.org/article/2caaceed62ab4c7c8857419d6654e691
Autor:
Se-Young Jung, Eun-Young Kim
Publikováno v:
Journal of Korean Academy of Nursing; Nov2024, Vol. 54 Issue 4, p563-576, 14p
Publikováno v:
Journal of Cardiovascular Medicine; Nov2024, Vol. 25 Issue 11, p781-788, 8p
Autor:
Se Yong Jung, Min Seo Kim, Han Li, Keum Hwa Lee, Ai Koyanagi, Marco Solmi, Andreas Kronbichler, Elena Dragioti, Kalthoum Tizaoui, Sarah Cargnin, Salvatore Terrazzino, Sung Hwi Hong, Ramy Abou Ghayda, Nam Kyun Kim, Seo Kyoung Chung, Louis Jacob, Joe‐Elie Salem, Dong Keon Yon, Seung Won Lee, Karel Kostev, Ah Young Kim, Jo Won Jung, Jae Young Choi, Jin Soo Shin, Soon‐Jung Park, Seong Woo Choi, Kiwon Ban, Sung‐Hwan Moon, Yun Young Go, Jae Il Shin, Lee Smith
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 2, Pp 501-513 (2022)
Abstract On October 2020, the US Food and Drug Administration (FDA) approved remdesivir as the first drug for the treatment of coronavirus disease 2019 (COVID‐19), increasing remdesivir prescriptions worldwide. However, potential cardiovascular (CV
Externí odkaz:
https://doaj.org/article/193ae135de354dc99bb9951ef20e5f30